Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation

American Journal of Clinical Pathology

Volumn 110, Issue 1, 1998, Pages 84-94

  Wells, Denise A ^a,b   Sale, George E ^a   Shulman, Howard M ^a   Myerson, David ^a   Bryant, Eileen M ^a   Gooley, Theodore ^a   Loken, Michael R ^a,b  

^a USA   (United States)

^b HEMATOLOGICS INC   (United States)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Bone marrow transplantation; Cytogenetics; Hematogones; Hematopoietic diseases; Immunophenotyping; Morphology; Multidimensional flow cytometry; Relapse

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CELL SEPARATION; CHILD; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031781719     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.1.84     Document Type: Article

References (39)

1. Davis RE, Longacre TA, Cornbleet PJ. Hematogones in the bone marrow of adults: immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol. 1994;102:202-211.
2. Self SE, Morgan S, Grush O, et al. Significance of common acute lymphoblastic antigen (CALLA) positive cells in bone marrow of children off therapy in complete remission. Hematol Oncol. 1990;8:91-95.
3. Sandhaus LM, Chen TL, Ettinger LJ, et al. Significance of increased proportion of CD10-positive cells in nonmalignant bone marrows of children. Am J Pediatr Hematol Oncol. 1993;15:65-70.
4. Muehleck SD, McKenna RW, Gale PF, et al. Terminal deoxynucleotidyl transferase (TdT)-positive cells in bone marrow in the absence of hematologic malignancy. Am J Clin Pathol. 1983;79:277-284.
5. van den Doel LJ, Pieter R, Huisman DR, et al. Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia. Eur J Haematol. 1988;41:170-175.
6. Ifrah N, Boucheix C, Marie JP, et al. Persistence of bone marrow lymphocytosis after induction treatment in common acute lymphoblastic leukemia: marker analysis and significance. Cancer. 1986;58:2018-2022.
7. Breslow N, Zandstra R. A note on the relationship between bone marrow lymphocytosis and remission duration in acute leukemia. Blood. 1970;36:246-249.
8. Schuurmans Stekhoven JH, Langenhuysen CA, Bakkeren JA, et al. Morphology and incidence of the "posttherapeutic lymphoid cell" in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1986;124:46-52.
9. Haumann TJ, van Wering ER, van der Does-van den Berg A, et al. Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1992;9:41-47.
10. Campana D, Coustan-Smith E, Janossy G. The immunological detection of minimal residual disease in acute leukemia. Blood. 1990;76:163-171.
11. Longacre TA, Foucar K, Crago S, et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood. 1989;73:543-552.
12. Janossy G, Bollum FJ, Bradstock KF, et al. Terminal deoxynucleotidyl transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol. 1979;123:1525-1529.
13. Ryan DH, Chapple CW, Kossover SA, et al. Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood. 1987;70:814-821.
14. Ryan D, Kossover S, Mitchell S, et al. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood. 1986; 68:417-425.
15. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow, II: normal B lymphocyte development. Blood. 1987;70:1316-1324.
16. Loken MR, Shah VO, Hollander Z, et al. Flow cytometric analysis of normal B lymphoid development. Pathol Immunopathol Res. 1988;7:357-370.
17. Loken MR. Multidimensional data analysis in immunophenotyping. In: Robinson PJ, ed. Current Protocols in Cytometry. New York, NY: Wiley-Liss; 1997.
18. Hurwitz CA, Loken MR, Graham ML, et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood. 1988;72:299-307.
19. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci. 1993;677:265-280.
20. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100: 534-540.
21. Rainer RO, Hodges L, Stelzer GT. CD45 gating correlates with bone marrow differential. Cytometry. 1995;22:139-145.
22. Durnam DM, Anders KR, Fisher L, et al. Analysis of the origin of marrow cells in BMT recipients using a Y chromosome specific in situ hybridization assay. Blood. 1989;74: 2220-2226.
23. Cox DR. Regression models and life tables (with discussion) JR Stat Soc. 1972;34:187-220.
24. Cox DR, Oakes D. Analysis of Survival Data. New York, NY: Chapman and Hall; 1984:35.
25. Terstappen LWMM, Huang S, Picker L. Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 1992;79:666-677.
26. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies: Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10:877-895.
27. Harris NA, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
28. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow, III: neutrophil maturation. Leukemia. 1990;4:657-663.
29. Uckun FM, Kersey JH, Haake R, et al. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med. 1993;329:1296-1301.
30. Wormann B, Konemann S, Safford M, et al. Immunophenotypic heterogeneity of leukemic cells in AML at diagnosis and after chemotherapy [abstract]. Blood. 1990;76(suppl):337a.
31. Langlands K, Goulden NJ, Steward CG, et al. False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. Blood. 1994;84:1352-1353.
32. Roberts WM, Estrov Z, Ouspenskaia MV, et al. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med. 1997;336:317-323.
33. Radich JP, Kopecky KJ, Appelbaum F, et al. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia. 1994;10:1688-1695.
34. Drach J, Drach D, Huber H, et al. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry. 1992;13: 893-901.
35. Greaves MF, Paxton A, Lister TA, et al. Acute lymphoblastic leukaemia associated antigen, III: alterations in expression during treatment and in relapse. Leuk Res. 1980;4:1-14.
36. Stass S, Mirro J, Williams D, et al. Lineage switch in acute leukemia. Blood. 1984;64:318-320.
37. LeBien TW, Wormann B, Loken MR, et al. Multiparameter flow cytometric analysis of human fetal bone marrow B cells. Leukemia. 1990;4:354-358.
38. Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol. 1994;8:1710-1717.
39. Steinherz PG, Redner A, Steinherz L, et al. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse: the Memorial Sloan-Kettering - New York-II protocol. Cancer. 1993;72:3120-3130.